Startup Funding Tracker
Home›People›Erez Chimovits
Erez Chimovits

Erez Chimovits

Director at ADARx Pharmaceuticals. Also a senior managing director at orbimed at Fore Biotherapeutics, a director at ImmPACT Bio USA and Capstan Therapeutics and an executive officer at OrbiMed Partners.

InvestorDirectorPublic companyRoles at 4 startupsOrbiMed Partners
Updated Nov 10, 2026·Latest SEC filing Sep 30, 2026·Suggest an edit

About Erez Chimovits

Erez Chimovits is a director at ADARx Pharmaceuticals.

Form D filings also name Erez Chimovits as a senior managing director at orbimed at Fore Biotherapeutics and a director at ImmPACT Bio USA and Capstan Therapeutics.

Erez Chimovits reports to the SEC as a director or major shareholder of 7 public companies, including Braveheart Bio (BRVE), Upstream Bio (UPB) and BiomX (PHGE).

Erez Chimovits appears on fund filings for OrbiMed Partners.

Erez Chimovits first appears on SEC filings in 2011.

Experience

This experience comes from SEC filings. The years are when the filings name Erez Chimovits in the role, so the role may have started earlier or lasted longer.

ADARx Pharmaceuticals, Inc.
Director
2020 – 2026 · Public company (ADRX)
Braveheart Bio, Inc.
Director and 10% owner
2026 · Public company (BRVE)
FORE US Bio Inc.
Senior Managing Director at Orbimed
2023 – 2026 · Philadelphia, PA
Develops targeted cancer drugs for patients whose tumors have specific genetic changes.
Upstream Bio, Inc.
Director and 10% owner
2024 – 2026 · Public company (UPB)
BiomX Inc.
Director and 10% owner
2019 – 2024 · Public company (PHGE)
ImmPACT Bio USA Inc.
Director
2020 – 2024 · West Hills, CA
Capstan Therapeutics, Inc.
Director
2024 · San Diego, CA
Adicet Bio, Inc.
Director and 10% owner
2020 – 2023 · Public company (ACET)
LogicBio Therapeutics, Inc.
Director and 10% owner
2018 – 2020 · Public company (LOGC)
Eledon Pharmaceuticals, Inc.
Director and 10% owner
2017 – 2020 · Public company (ELDN)
OrbiMed Partners
Executive officer
2011 – 2015 · Fund filings for 2 funds

Key Colleagues at Startups

The people Erez Chimovits works with at each company, as listed on that company's latest Form D.

FORE US Bio Inc. · Form D/A, Jul 14, 2026
William Hinshaw
William Hinshaw
Executive officer and director
Michael Byrnes
Michael Byrnes
Chief Financial Officer
Giovanni Mariggi
Giovanni Mariggi
Co-founder and Partner at Medicxi, director
Kim Blackwell
RD
Rajeev Dadoo
COO and Managing Partner of SR One, director
Dieter Weinand
Dieter Weinand
Chairman of the Board
Chandra Leo
Chandra Leo
Partner at HBM Partners and director
ImmPACT Bio USA Inc. · Form D/A, Apr 2, 2024
YC
Yvonne Chen
Director
HL
Han Lee
Executive officer
MS
XC
Xiangmin Cui
Director
SG
SR
Sumant Ramachandra
President and Chief Executive Officer, director
YY
CX
Cindy Xiong
Director
Capstan Therapeutics, Inc. · Form D, Mar 20, 2024
FP
Fabio Pucci
Director
NS
MS
AC
RJ
Rajul Jain
Director
LS
Laura Shawver
President and CEO, director
RF
Ramin Farzaneh-Far
Executive officer
JT
Justin Thacker
Executive officer
MB
AB
Adrian Bot
Executive officer
NL
PK
Priya Karmali
Executive officer
KS
Karen Smith
Director
ADARx Pharmaceuticals, Inc. · Form D, Aug 10, 2023
RZ
Rui Zhu
Executive officer
SG
JL
Judith Li
Director
SG
ZL
Zhen Li
President and Chief Executive Officer, director
YS
CY
Chen Yu
Director
RS
Ricky Sun
Director
LK
Lorence Kim
Director
CG
Carl Gordon
Director

Sources

  1. SECFORE US Bio Inc. Form D/A, filed Jul 14, 2026
  2. SECImmPACT Bio USA Inc. Form D/A, filed Apr 2, 2024
  3. SECCapstan Therapeutics, Inc. Form D, filed Mar 20, 2024
  4. SECADARx Pharmaceuticals, Inc. Form D, filed Aug 10, 2023
  5. SECForms 3, 4 and 5 filed by Erez Chimovits (SEC filer 1706399)